These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 16574456)

  • 1. Alloimmunity to RhD in humans.
    Urbaniak SJ
    Transfus Clin Biol; 2006; 13(1-2):19-22. PubMed ID: 16574456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
    Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
    Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
    Brinc D; Lazarus AH
    Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
    Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
    Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
    Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
    Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
    Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
    Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rh proteins: key structural and functional components of the red cell membrane.
    Van Kim CL; Colin Y; Cartron JP
    Blood Rev; 2006 Mar; 20(2):93-110. PubMed ID: 15961204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A curious case of anti-D antibody titer.
    Hensley JG; Coughlin KP; Klein LL
    J Midwifery Womens Health; 2009; 54(6):497-502. PubMed ID: 19879523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 14. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do we need to be more concerned about weak D antigens?
    Garratty G
    Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Alloimmunization to a high frequency Rh antigen].
    Cotorruelo C; Biondi C; Borras SG; Racca L; Brunetti D; Di Monaco R; Racca A
    Medicina (B Aires); 2006; 66(1):46-8. PubMed ID: 16555729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of maternal plasma for prenatal RhD blood group genotyping.
    Finning K; Martin P; Daniels G
    Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-c antibodies as a cause of severe form of hemolytic disease of the newborn].
    Sławek Z; Stolarz E; Banaszkiewicz A; Walczak Z; Surowiec E
    Acta Haematol Pol; 1988; 19(1-2):71-4. PubMed ID: 3149113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.